Insider Transactions in Q1 2022 at Cme Group Inc. (CME)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 25
2022
|
William R Shepard Director |
BUY
Small Acquisition
|
Direct |
8
+0.38%
|
$1,960
$245.59 P/Share
|
|
Mar 16
2022
|
Ken Vroman Chief Transformation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
73
-0.55%
|
$17,666
$242.01 P/Share
|
|
Mar 15
2022
|
Kathleen M Cronin Sr MD Gen Counsel & Corp Secr |
SELL
Bona fide gift
|
Direct |
280
-0.67%
|
-
|
|
Mar 15
2022
|
Kathleen M Cronin Sr MD Gen Counsel & Corp Secr |
SELL
Payment of exercise price or tax liability
|
Direct |
881
-2.07%
|
$204,392
$232.0 P/Share
|
|
Mar 15
2022
|
Kathleen M Cronin Sr MD Gen Counsel & Corp Secr |
BUY
Grant, award, or other acquisition
|
Direct |
2,542
+5.63%
|
$589,744
$232.0 P/Share
|
|
Mar 15
2022
|
Julie Winkler Sr MD Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
749
-2.53%
|
$173,768
$232.0 P/Share
|
|
Mar 15
2022
|
Julie Winkler Sr MD Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,243
+7.04%
|
$520,376
$232.0 P/Share
|
|
Mar 15
2022
|
Suzanne Sprague Sr MD Global Head of Clearing |
BUY
Grant, award, or other acquisition
|
Direct |
1,242
+14.93%
|
$288,144
$232.0 P/Share
|
|
Mar 15
2022
|
Suzanne Sprague Sr MD Global Head of Clearing |
SELL
Payment of exercise price or tax liability
|
Direct |
66
-2.5%
|
$15,312
$232.0 P/Share
|
|
Mar 15
2022
|
Sunil Cutinho Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
929
-2.27%
|
$215,528
$232.0 P/Share
|
|
Mar 15
2022
|
Sunil Cutinho Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,542
+5.85%
|
$589,744
$232.0 P/Share
|
|
Mar 15
2022
|
Ken Vroman Chief Transformation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
103
-0.77%
|
$23,896
$232.0 P/Share
|
|
Mar 15
2022
|
Ken Vroman Chief Transformation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
349
+2.54%
|
$80,968
$232.0 P/Share
|
|
Mar 15
2022
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
BUY
Grant, award, or other acquisition
|
Direct |
1,246
+15.39%
|
$289,072
$232.0 P/Share
|
|
Mar 15
2022
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
SELL
Payment of exercise price or tax liability
|
Direct |
73
-2.95%
|
$16,936
$232.0 P/Share
|
|
Mar 15
2022
|
Jack J Tobin MD Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,295
+4.91%
|
$532,440
$232.0 P/Share
|
|
Mar 15
2022
|
Jack J Tobin MD Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
73
-0.37%
|
$16,936
$232.0 P/Share
|
|
Mar 15
2022
|
Terrence A Duffy Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,638
-5.05%
|
$1,076,016
$232.0 P/Share
|
|
Mar 15
2022
|
Terrence A Duffy Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,468
+10.24%
|
$2,428,576
$232.0 P/Share
|
|
Mar 15
2022
|
John W. Pietrowicz Sr MD Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,331
-2.48%
|
$308,792
$232.0 P/Share
|
|
Mar 15
2022
|
John W. Pietrowicz Sr MD Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,290
+5.78%
|
$763,280
$232.0 P/Share
|
|
Mar 15
2022
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
SELL
Payment of exercise price or tax liability
|
Direct |
905
-7.75%
|
$209,960
$232.0 P/Share
|
|
Mar 15
2022
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
BUY
Grant, award, or other acquisition
|
Direct |
2,542
+17.88%
|
$589,744
$232.0 P/Share
|
|
Mar 15
2022
|
Lynne Fitzpatrick Sr MD Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,251
+6.34%
|
$290,232
$232.0 P/Share
|
|
Mar 15
2022
|
Lynne Fitzpatrick Sr MD Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
68
-0.82%
|
$15,776
$232.0 P/Share
|
|
Mar 15
2022
|
Sean Tully Sr MD Global Hd Rates & OTC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,153
-5.56%
|
$267,496
$232.0 P/Share
|
|
Mar 15
2022
|
Sean Tully Sr MD Global Hd Rates & OTC |
BUY
Grant, award, or other acquisition
|
Direct |
2,692
+11.5%
|
$624,544
$232.0 P/Share
|
|
Mar 15
2022
|
Julie Holzrichter Sr MD Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,085
-2.97%
|
$251,720
$232.0 P/Share
|
|
Mar 15
2022
|
Julie Holzrichter Sr MD Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,841
+7.21%
|
$659,112
$232.0 P/Share
|
|
Mar 15
2022
|
Hilda Harris Piell Sr MD & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
792
-2.04%
|
$183,744
$232.0 P/Share
|
|
Mar 15
2022
|
Hilda Harris Piell Sr MD & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,393
+5.8%
|
$555,176
$232.0 P/Share
|
|
Mar 14
2022
|
Sean Tully Sr MD Global Hd Rates & OTC |
SELL
Open market or private sale
|
Direct |
4,000
-9.08%
|
$916,000
$229.81 P/Share
|
|
Mar 11
2022
|
Kathleen M Cronin Sr MD Gen Counsel & Corp Secr |
SELL
Bona fide gift
|
Direct |
283
-0.7%
|
-
|
|
Mar 11
2022
|
Kathleen M Cronin Sr MD Gen Counsel & Corp Secr |
SELL
Open market or private sale
|
Direct |
4,000
-9.02%
|
$908,000
$227.15 P/Share
|
|
Mar 11
2022
|
Sean Tully Sr MD Global Hd Rates & OTC |
SELL
Open market or private sale
|
Direct |
3,000
-11.98%
|
$687,000
$229.0 P/Share
|
|
Mar 03
2022
|
Hilda Harris Piell Sr MD & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
2,000
-5.2%
|
$488,000
$244.0 P/Share
|
|
Mar 01
2022
|
Daniel R Glickman Director |
SELL
Open market or private sale
|
Direct |
750
-5.0%
|
$175,500
$234.3 P/Share
|
|
Feb 24
2022
|
Hilda Harris Piell Sr MD & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
1,500
-3.76%
|
$351,000
$234.01 P/Share
|
|
Feb 14
2022
|
Sunil Cutinho Chief Information Officer |
SELL
Open market or private sale
|
Direct |
4,900
-11.32%
|
$1,161,300
$237.96 P/Share
|
|
Feb 10
2022
|
Kevin Kometer Sr MD Chief Information Office |
SELL
Open market or private sale
|
Direct |
13,500
-6.21%
|
$3,294,000
$244.29 P/Share
|
|
Feb 10
2022
|
Elizabeth A Cook Director |
SELL
Open market or private sale
|
Indirect |
1,000
-5.07%
|
$244,000
$244.25 P/Share
|
|
Feb 10
2022
|
Charles P Carey Director |
SELL
Open market or private sale
|
Indirect |
3,000
-15.2%
|
$732,000
$244.36 P/Share
|
|
Jan 25
2022
|
Dennis Chookaszian Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+1.36%
|
-
|
|
Jan 25
2022
|
Howard J Siegel Director |
BUY
Grant, award, or other acquisition
|
Direct |
75
+0.1%
|
$16,575
$221.79 P/Share
|
|
Jan 25
2022
|
Dennis Suskind Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+1.46%
|
$10,387
$221.79 P/Share
|
|
Jan 25
2022
|
Ana Dutra Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+0.72%
|
$10,387
$221.79 P/Share
|
|
Jan 25
2022
|
Phyllis M Lockett Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+2.39%
|
$10,387
$221.79 P/Share
|
|
Jan 25
2022
|
Terry L Savage Director |
BUY
Grant, award, or other acquisition
|
Indirect |
47
+0.25%
|
$10,387
$221.79 P/Share
|
|
Jan 25
2022
|
William R Shepard Director |
BUY
Grant, award, or other acquisition
|
Indirect |
75
+0.04%
|
$16,575
$221.79 P/Share
|
|
Jan 25
2022
|
Bryan T Durkin Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+0.07%
|
$10,387
$221.79 P/Share
|